Relative risks, Absolute problems

by Kazeem Olalekan MRPharmS A news article in the Pharmaceutical Journal online caught my attention. The news relates to a Cochrane review which indicated that “relative risk reduction should not be reported alone when communicating information about health interventions’ since they do not allow a fair comparison of benefits and harms”. I couldn’t agree more. […]